Source: Axon Enterprise Form 8-K Exhibit 99.1, Forward-Looking Operating Metrics / key metrics table, Annual recurring revenue. Five sequential period-end columns, newest first; later filing wins. Pre-2023 prints were in thousands and converted to nearest million to match the file unit; Q1 2024 restated 2023 ARR (Q4 2023 from $697 million to $732 million). Window Q3 2021–Q2 2026. Latest: https://www.sec.gov/Archives/edgar/data/1069183/000162828026053363/axon-20260805xex991.htm.

Source: Axon Enterprise Form 8-K Exhibit 99.1, Forward-Looking Operating Metrics table, Future contracted bookings ($ billions). Period-end stock of unfulfilled contracted orders (RPO plus contracts with termination clauses). Label began Q4 2024; earlier 'total company future contracted revenue' was RPO and is not mixed in. Later filing wins. Window Q4 2023–Q2 2026. Latest: https://www.sec.gov/Archives/edgar/data/1069183/000162828026053363/axon-20260805xex991.htm.

Source: Axon Enterprise Form 8-K Exhibit 99.1, Forward-Looking Operating Metrics / key metrics table, Net revenue retention. Period-end stock; later filing wins. Window Q3 2021–Q2 2026. Latest: https://www.sec.gov/Archives/edgar/data/1069183/000162828026053363/axon-20260805xex991.htm.

Source: Axon Enterprise Form 10-K for the year ended 31 December 2025 (RPO $9.9 billion): https://www.sec.gov/Archives/edgar/data/1069183/000162828026011360/axon-20251231.htm. Form 10-K for the year ended 31 December 2024 (RPO $7.9 billion): https://www.sec.gov/Archives/edgar/data/1069183/000106918325000019/axon-20241231.htm. Form 10-Q for the quarter ended 31 March 2026 (RPO $9.7 billion): https://www.sec.gov/Archives/edgar/data/1069183/000162828026031542/axon-20260331.htm.